Table 2.
Comparison of characteristic in COVID-19 infected patients.
| Fully vaccinated (n = 543) | Partially vaccinated (n = 20) | Unvaccinated (n = 577) | p-value | |
|---|---|---|---|---|
| Age, year | 65.74 (11.9) | 66.35 (9.76) | 64.17 (14.16) | 0.117 |
| Sex | ||||
| Women | 212 (39.0) | 12 (60.0) | 238 (41.2) | 0.152 |
| Men | 331 (61.0) | 8 (40.0) | 339 (58.8) | |
| Medicaid beneficiary | 125 (23.0) | 8 (40.0) | 146 (25.3) | 0.179 |
| Residence | 0.562 | |||
| metropolitan | 382 (70.3) | 12 (60.0) | 410 (71.1) | |
| Non-metropolitan | 161 (29.7) | 8 (40.0) | 167 (28.9) | |
| Comorbid conditions | ||||
| Diabetes | 331 (61.0) | 16 (80.0) | 337 (58.4) | 0.125 |
| Hypertension | 384 (70.7) | 17 (85.0) | 407 (70.5) | 0.373 |
| Heart failure | 54 (9.9) | 3 (15.0) | 54 (9.4) | 0.687 |
| Ischemic heart disease | 125 (23.0) | 7 (35.0) | 116 (20.1) | 0.174 |
| Stroke | 21 (3.9) | 1 (5.0) | 30 (5.2) | 0.563 |
| COPD | 26 (4.8) | 1 (5.0) | 34 (5.9) | 0.712 |
| Liver disease | 34 (6.3) | 2 (10.0) | 38 (6.6) | 0.794 |
| Cancer | 20 (3.7) | 1 (5.0) | 13 (2.3) | 0.322 |
COPD, chronic obstructive lung disease.